Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries
Acta Neurologica Scandinavica2014Vol. 129(198), pp. 26–31
Citations Over TimeTop 10% of 2014 papers
Abstract
This study confirms an optimal and unbiased case finding in both databases. Our calculated prevalence and incidence rates are in line with previous population-based studies. There was good agreement in prevalence reported from the two databases. The discrepancy in incidence is expected to diminish as years of study are increasing in NorPD.
Related Papers
- → The utility of a single simple question in the evaluation of patients with myasthenia gravis(2017)39 cited
- → Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor(2008)29 cited
- → Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata(2012)23 cited
- [Myasthenia gravis--an autoimmune neuromuscular disease].(2000)
- → Cohort profile: COVID-19 in a cohort of pregnant women and their descendants, the MOACC-19 study(2020)